Brief: Agios To Receive $1.1 Billion In Milestone Payments Following FDA Approval Of Vorasidenib
Aug 6 (Reuters) - Agios Pharmaceuticals Inc AGIO.O :
* AGIOS TO RECEIVE $1.1 BILLION IN MILESTONE PAYMENTS
FOLLOWING
FDA APPROVAL OF VORASIDENIB
* AGIOS PHARMACEUTICALS INC - EXPECTS $905 MILLION PAYMENT
FROM
ROYALTY PHARMA IN Q3 2024
* AGIOS PHARMACEUTICALS INC - TO PREPARE FOR POTENTIAL
PYRUKYND
LAUNCHES IN 2025 AND 2026
Source text for Eikon: ID:nGNX88yHvk
Further company coverage: AGIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agios Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Agios Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Agios Q2 revenue jumps on US commercial launch of AQVESME
Brief: Agios Pharmaceuticals Q2 Product Revenue USD 44.745 Million Vs. IBES Estimate USD 25.5 Million